<DOC>
	<DOCNO>NCT01751438</DOCNO>
	<brief_summary>The goal clinical research study learn treatment standard systemic therapy ( androgen deprivation therapy bilateral orchiectomy ) combination surgery radiation therapy effective control prostate cancer standard systemic therapy alone . The safety treatment combination also study .</brief_summary>
	<brief_title>Best Systemic Therapy Best Systemic Therapy ( BST ) Plus Definitive Treatment ( Radiation Surgery )</brief_title>
	<detailed_description>Study Groups : If find eligible take part study , randomly assign ( flip coin ) 1 2 study group 6 month ( +/- 14 day ) start standard systemic therapy . You equal chance assign group . - If Group 1 , continue receive standard care systemic treatment . - If Group 2 , receive standard care systemic treatment addition surgery remove prostate radiation therapy prostate . You treat physician decide surgery radiation therapy best choice . Your treat physician explain surgery radiation therapy risk detail , ask sign separate consent form procedure . If disease get bad within first 6 month receive standard systemic therapy , assign study group . You may able continue receive standard systemic therapy doctor think best interest . You may choose participate study allow study team collect information follow study visit describe : within 60 day screen , end-of-treatment , long-term followup . Study Visits : Within 60 day screen : - You physical exam , include digital rectal exam ( DRE ) . - You ask well able perform normal activity daily live ( performance status ) . - Blood ( 2-3 teaspoon ) draw routine test , check prostate-specific antigen ( PSA ) level , testosterone level . - Urine collect routine test . - You complete questionnaire feeling . It take 15 minute complete . - You bone scan , 2 CT scan abdomen pelvis , chest X-ray compute tomography ( CT ) scan chest check status disease . - You endorectal Magnetic Resonance Imaging ( MRI ) scan prostate check status disease . Every 12 week ( +/- 14 day ) study ( start month 9 ) : - You physical exam , include DRE update medical history record . - You ask side effect may . - You ask drug treatment may receive , include over-the-counter drug , herbal remedy , vitamin , and/or supplement . - Blood ( 2-3 teaspoon ) draw routine test , check liver function , measure PSA testosterone level . - You complete questionnaire feeling . It take 15 minute complete . - If study doctor think need , CT/MRI image scan check status disease . If side effect 12-month visit , give PSA kit send sample test PSA level . You need blood ( 1 teaspoon ) drawn local doctor 's office lab mail kit , every 3 month . The package provide , need pay postage . You would still need visit clinic every 6 month . The study staff tell . Length Treatment : You may continue participation study long doctor think best interest . You take study treatment disease get bad , intolerable side effect occur , unable follow study direction . Your active participation study long-term follow-up phone calls/emails ( describe ) . End-of-Treatment Visit : Within 14 day study treatment stop , follow test procedure perform : - You physical exam , include DRE . - You ask side effect may . - You ask drug treatment may receive , include over-the-counter drug , herbal remedy , vitamin , and/or supplement . - Blood ( 2-3 teaspoon ) draw routine test , check liver function , measure PSA testosterone level . - Urine collect biomarker test . - You complete questionnaire feeling . It take 15 minute complete . - If study doctor think need , CT/MRI image scan check status disease . Long-Term Follow-Up : Every 6 month end-of-treatment visit 10 year , contact phone e-mail , ask question feel . Each phone call last 5 minute . If able contact phone email , study doctor review record update medical record . This investigational study . Using standard care systemic treatment surgery , and/or radiation therapy FDA approve commercially available . Up 180 patient take part multi-center study . Up 180 patient enrol MD Anderson .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Male patient 2 . 18 yrs old 3 . Histologically cytologically proven prostate carcinoma 4 . Documented evidence M1 disease AJCC ( American Joint Committee Cancer ) stag Bone scan , CT and/or MRI . 5 . Androgen dependent disease measure decline PSA display sign progression demonstrate rise PSA . 6 . Treatment initiation BST longer 6 month prior randomization 7 . ECOG PS 0 1 8 . Lifeexpectancy base comorbid condition &gt; 2 year 9 . Ability understand willingness sign inform consent 10 . Must candidate surgery and/or radiation therapy 1 . Psychiatric medical condition , opinion treat physician , would allow patient undergo propose treatment safely . 2 . Known brain metastasis 3 . Small cell carcinoma prostate 4 . Any laboratory abnormality , opinion investigator , may put subject risk participate study . For example : AST + ACT &gt; 2 upper limit normal value ; WBC &lt; 2.0 ; Hgb &lt; 7.0 .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>Prostate carcinoma</keyword>
	<keyword>Metastatic</keyword>
	<keyword>M1</keyword>
	<keyword>Best Systemic Therapy</keyword>
	<keyword>BST</keyword>
	<keyword>Androgen deprivation therapy</keyword>
	<keyword>Bilateral orchiectomy</keyword>
	<keyword>Radiation</keyword>
	<keyword>Radiation Therapy</keyword>
	<keyword>External beam radiation therapy</keyword>
	<keyword>External-beam radiotherapy</keyword>
	<keyword>Xray therapy</keyword>
	<keyword>XRT</keyword>
	<keyword>Surgery</keyword>
</DOC>